Customer Interview
Unraveling the Genetic Contributions of Cognitive Control
Neuroscience researchers are using NGS to identify variants for a new sequencing array designed for ADHD, autism, and schizophrenia studies.
Read Article
Customer Interview
NGS Identifies Rare Disease Variants in Infants with Undiagnosed...
Landmark NGS study leads to a national clinical diagnostic exome sequencing platform in Singapore.
Read Article
Customer Videos
The Power of iHope
Families of children with an undiagnosed disease often face years-long diagnostic odysseys. Hear from health care providers and families who...
View VideoJoin us at ASHG 2019 Annual Meeting, October 15 - 19
Visit booth 727 to explore our genomic solutions
Learn MoreTraining and Webinars
Illumina offers webinars and free online training courses to get the most out of your experiments and products
View WebinarsView CoursesFeatured Tool
Sequencing Platform Comparison Tool
Compare sequencing systems and find the right one for your lab or application
Launch ToolPopular Tools
-
MyIllumina Customer Dashboard
Sign In or Learn More -
Library Prep and Array Kit Selector
Launch Tool -
BaseSpace Sequence Hub
Sign In or Learn More -
Custom Protocol Selector
Build Protocol -
DesignStudio Custom Assay Designer
Sign In or Learn More
See More Tools
Featured News
Illumina Hosts Calif. Assembly Select Committee on Biotech & Rare Disease Caucus
Project Baby Bear briefing highlights progress and impact
Read Article| Date | Publication | Title |
|---|---|---|
| Oct 16, 2019 | NPR | A Boy's Mysterious Illness Leads His Family On A Diagnostic Odyssey |
| Oct 9, 2019 | Yahoo! Finance | Illumina Inks Deal to Commercialize NGS-Based IVD Kits |
| Sep 30, 2019 | ClinicalOMICs | Illumina and the Broad Co-Developing Open-Source Secondary Analysis Software |